REMIX
Price
$14.47
Change
-$0.08 (-0.55%)
Updated
Oct 17 closing price
Net Assets
742.38M
WGLSX
Price
$12.44
Change
+$0.10 (+0.81%)
Updated
Oct 17 closing price
Net Assets
40.56M
Interact to see
Advertisement

REMIX vs WGLSX

Header iconREMIX vs WGLSX Comparison
Open Charts REMIX vs WGLSXBanner chart's image
Standpoint Multi-Asset Investor
Price$14.47
Change-$0.08 (-0.55%)
VolumeN/A
Net Assets742.38M
Wasatch Long/Short Alpha Institutional
Price$12.44
Change+$0.10 (+0.81%)
VolumeN/A
Net Assets40.56M
REMIX vs WGLSX Comparison Chart in %
View a ticker or compare two or three
VS
REMIX vs. WGLSX commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is REMIX is a Hold and WGLSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
REMIX has more cash in the bank: 742M vs. WGLSX (40.6M). REMIX pays higher dividends than WGLSX: REMIX (5.52) vs WGLSX (0.00). REMIX was incepted earlier than WGLSX: REMIX (6 years) vs WGLSX (4 years). WGLSX (2.09) is less costly to investors than REMIX (1.64). REMIX has a lower initial minimum investment than WGLSX: REMIX (2500) vs WGLSX (100000). REMIX annual gain was more profitable for investors over the last year : 0.74 vs. WGLSX (-21.37).
REMIXWGLSXREMIX / WGLSX
Total Expense Ratio1.512.0773%
Annual Report Gross Expense Ratio1.642.0978%
Fund Existence6 years4 years-
Gain YTD1.473-12.085-12%
Front LoadN/AN/A-
Min. Initial Investment25001000003%
Min. Initial Investment IRAN/AN/A-
Net Assets742M40.6M1,828%
Annual Yield % from dividends5.520.00-
Returns for 1 year0.74-21.37-3%
Returns for 3 years13.3633.1940%
Returns for 5 years53.38N/A-
Returns for 10 yearsN/A41.78-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BDOUF2.62N/A
N/A
BDO Unibank Inc.
ECAOF0.10N/A
N/A
Eco Atlantic Oil & Gas Ltd
MHSDF3.25N/A
N/A
Megacable Holdings SAB DE CV
EDTXF1.10-0.02
-2.14%
Spectral Medical Inc.
RGBP0.01N/A
-7.14%
Regen Biopharma, Inc.